ArticleMedicine2026
Genetically predicted circulating polyunsaturated fatty acids and Crohn's disease susceptibility: A two-sample mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Crohn disease (CD) remains an increasing global health burden. Omega-3 and omega-6 polyunsaturated fatty acids participate in lipid metabolism and inflammatory regulation, but previous observational and interventional studies have produced inconsistent findings. This study aimed to assess whether genetically predicted circulating omega-3, omega-6, and the omega-6/omega-3 ratio are associated with CD susceptibility using a two-sample Mendelian randomization (MR) design. Genome-wide association study summary data for circulating omega-3, omega-6, and the omega-6/omega-3 ratio were obtained from the IEU Open GWAS project (each n = 114,999), while CD outcome data included 12,194 cases and 28,072 controls. Genome-wide significant single-nucleotide polymorphisms (P < 5 × 10-8) were clumped at r2 = 0.001 within 10,000 kb, and all retained instruments had F-statistics > 10. Multiplicative random-effects inverse-variance weighting was used as the primary analysis, supplemented by MR-Egger, weighted median, simple mode, and weighted mode methods. Heterogeneity, horizontal pleiotropy, and robustness were evaluated using Cochran's Q test, the MR-Egger intercept, leave-one-out analysis, and funnel plots. A total of 46 single-nucleotide polymorphisms for omega-3, 51 for omega-6, and 34 for the omega-6/omega-3 ratio were included. Higher genetically predicted circulating omega-3 levels were associated with lower odds of CD (odds ratio [OR] = 0.823, 95% confidence interval [CI] 0.721-0.939, P =.004), whereas omega-6 showed no statistically significant association (OR = 0.885, 95% CI 0.727-1.061, P =.186). A higher genetically predicted omega-6/omega-3 ratio was associated with increased odds of CD (OR = 1.211, 95% CI 1.069-1.372, P =.003). Complementary MR methods showed generally concordant directions, and MR-Egger intercept tests provided no statistical evidence of directional horizontal pleiotropy. However, substantial between-instrument heterogeneity was observed for all three exposures. These findings suggest that genetically predicted higher circulating omega-3 levels and a lower omega-6/omega-3 ratio are associated with lower CD susceptibility, whereas omega-6 alone shows no statistically significant association. Given the substantial between-instrument heterogeneity, these results should be regarded as suggestive genetic evidence rather than definitive proof of causality and should not be interpreted as evidence that dietary omega-3 intake or supplementation prevents CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.